You're a year out from your wedding, two years into building something, and the afternoons feel like someone unplugged you. A urgent-care panel came back "low normal" with a shrug — but you've read enough to know that some hormone paths can quietly close the door on kids, and that door isn't one you're ready to shut.
This is an educational comparison of two approaches a man in this exact spot might discuss with a provider: enclomiphene and testosterone therapy (often called TRT). It is not medical advice, and it is not a recommendation to take any specific drug. The point is to help you ask sharper questions.
Why "low normal" deserves a real conversation
Total testosterone is only part of the picture. The Endocrine Society's clinical practice guideline recommends diagnosing hypogonadism only in men with *consistent symptoms* and unequivocally low testosterone, confirmed on at least two morning measurements — not a single afternoon draw [1]. Levels follow a daily rhythm and dip later in the day, so timing alone can move a number from "fine" to "flagged."
The FDA notes that testosterone declines gradually with age and that the benefits and safety of treating age-related low testosterone are not established [2]. That's not a reason to dismiss symptoms — it's a reason to confirm the biochemistry properly and look at the *whole* axis (LH, FSH, estradiol, SHBG, and a semen analysis if fertility is on the table) before deciding anything.
The key distinction for you: the two approaches below act on opposite ends of the hormonal signaling chain.
Source: [1] Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline, [2] FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging
The mechanism that makes all the difference
Your brain runs testosterone production through the hypothalamic–pituitary–gonadal (HPG) axis. The pituitary releases luteinizing hormone (LH) and follicle-stimulating hormone (FSH); LH tells the testes to make testosterone, and FSH supports sperm production. Testosterone then signals back to the brain to dial that release down — a thermostat.
Testosterone therapy: helpful signal, suppressed factory
When testosterone is delivered from outside the body, the brain reads high circulating levels and turns down LH and FSH. With less LH and FSH, the testes reduce their own production — and sperm output can fall sharply, sometimes to zero. Reviews in the urology and endocrinology literature describe testosterone therapy as suppressing spermatogenesis, which is why it is not recommended for men who want to preserve fertility in the near term [3][4]. Recovery is common after stopping, but it can take months and isn't guaranteed on any fixed schedule.
Enclomiphene: turning the brain's signal back up
Enclomiphene is an estrogen-receptor modulator (the trans-isomer of clomiphene). By blocking estrogen feedback at the hypothalamus and pituitary, it can prompt the body to release *more* LH and FSH — encouraging the testes to produce testosterone using the body's own machinery. Because the signal moves through the normal axis rather than around it, this approach has been studied specifically for raising testosterone while keeping sperm production intact [5]. Note: enclomiphene is not currently an FDA-approved product; clomiphene-class therapy for low testosterone in men is generally used off-label, and a provider weighs that context with you.
The headline difference for someone planning a family: TRT typically *bypasses and suppresses* the factory; enclomiphene aims to *stimulate* it.
Source: [3] Treatment of male infertility secondary to morbid obesity (review of testosterone effects on spermatogenesis), [5] Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial
What a provider actually reviews around fertility
A careful independent provider doesn't jump to a molecule. The review usually includes:
- Confirmatory morning labs, drawn on two occasions, per guideline practice [1].
- The upstream hormones — LH and FSH — which reveal whether the issue is primarily in the testes (already high LH/FSH) or in the signaling from the brain (low or normal LH/FSH). This shapes whether stimulating the axis is even plausible.
- A baseline semen analysis when fertility matters, so there's a real starting point rather than an assumption.
- Estradiol and SHBG, since estrogen feedback and binding proteins affect both symptoms and strategy.
- Your timeline and goals — "kids in the next few years" is a different conversation than "kids someday" or "done having kids."
- Monitoring plans, including hematocrit. Testosterone therapy can raise red blood cell counts, and the FDA-approved labeling for testosterone products carries warnings including a possible increased risk of blood clots and cardiovascular events, which is why follow-up labs matter [2][6].
For men on testosterone who still want fertility, some protocols add agents intended to maintain testicular signaling — but those are individualized clinical decisions, not something to self-direct.
Honest tradeoffs, side by side
Neither path is "the energy drug." Both are tools with different profiles, and a prescription is never guaranteed — it's an independent provider's call after reviewing your data.
- TRT delivers a consistent external supply and is the more established treatment for confirmed hypogonadism, but it suppresses the HPG axis and can impair fertility while in use [3][4].
- Enclomiphene works by stimulating your own production and has been studied for preserving sperm parameters, which is why it draws interest from younger men — but the evidence base is younger and it isn't an FDA-approved drug for this use [5].
No legitimate provider should promise you a specific energy result or a specific testosterone number. The honest framing is: confirm the problem, match the mechanism to your fertility timeline, and monitor.
On the "is an online clinic legit" question
Fair skepticism. The thing that makes any path legitimate isn't the building — it's whether real labs are reviewed, whether a licensed provider makes the decision, and whether you're monitored over time. Your PCP shrugging at one afternoon draw isn't more rigorous than a structured workup that confirms levels properly and looks at the upstream hormones your fertility actually depends on.
*This article is educational and is not medical advice. Decisions about testing or treatment are made by an independent, licensed provider based on your individual evaluation.*
Where Velri fits
Velri is a technology and coordination company — it does not provide medical care. For men exploring this topic, Velri can help coordinate lab work, connect you with an independent, licensed provider group for an evaluation, and — *if* that provider determines treatment is appropriate and writes a prescription — coordinate fulfillment through an independent, licensed pharmacy. Whether anything is prescribed is always the independent provider's decision.
If a compounded medication is ever part of that conversation: Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
